Cases
Search
Statistics
Estimate
SEARCH
Show Filters
Decision Date
September, 2016
(2)
August, 2016
(1)
June, 2016
(1)
May, 2016
(1)
April, 2016
(1)
Decision
Transfer
(6)
Complainant
Boehringer Ingelheim International GmbH
(2)
E. Remy Martin & C°
(1)
Caviar Petrossian S.A.
(1)
Boehringer Ingelheim Pharma GmbH & Co. KG.
(1)
BOEHRINGER Ingelheim Pharma GmbH & Co. KG
(1)
Respondent
Williams Shorell
(1)
Vitalya, ARBITRAJ TRAFFIK
(1)
Pan Da Da
(1)
Maria Gendels
(1)
Lan Qing Tian / Qingtian Lan
(1)
Kelvin Baraka
(1)
Panelist
Sebastian M.W. Hughes
(1)
Jonathan Agmon
(1)
Douglas Clark
(1)
Assen Alexiev
(1)
Anthony R. Connerty
(1)
Alessandra Ferreri
(1)
Complainant Country
Germany
(4)
France
(2)
Complainant Representative
Nameshield
(6)
Respondent Country
Russia
(3)
China
(2)
United States
(1)
Respondent Reply
Yes
(2)
No
(4)
RDNH Status
No
(6)
Case Language
English
(6)
Case Particular
D
(6)
Number Of Domains
1
(4)
2
(1)
10
(1)
Domain Extension
top
(6)
vip
(1)
com
(1)
Domain Extension Type
newgTLD
(6)
gTLD
(1)
Domain Length
4
(1)
7
(3)
8
(1)
9
(2)
11
(1)
13
(1)
14
(1)
15
(1)
Includes Hyphen
Yes
(1)
No
(6)
Includes Number
Yes
(1)
No
(6)
Includes Letter
Yes
(6)
Domain Registrar
Chengdu West Dimension Digital Technology Co., Ltd.
(2)
West263 International Limited
(1)
PDR Ltd. d/b/a PublicDomainRegistry.com
(1)
GuangDong NaiSiNiKe Information Technology Co Ltd.
(1)
Alpnames Limited
(1)
1API GmbH
(1)
6
cases found.
Complainant Representative: Nameshield
Decision Date: 2016
Domain Extension: top
Reset Search
mirapex.top
Transfer
WIPO D2016-1585
(Decision Date: Sept. 30, 2016)
louisxiiicognac.top, louisxiiicognac.vip, louisxiii.vip and 7 others...
Transfer
WIPO D2016-1567
(Decision Date: Sept. 30, 2016)
alverta.top
Transfer
WIPO D2016-1202
(Decision Date: Aug. 17, 2016)
aggrenox.top, combivent.top
Transfer
WIPO D2016-0823
(Decision Date: June 9, 2016)
spiriva.top
Transfer
WIPO D2016-0537
(Decision Date: May 24, 2016)
ofev.top
Transfer
WIPO D2016-0486
(Decision Date: April 22, 2016)
Stay updated! Get new cases and decisions by daily email.
leave this field blank to prove your humanity
Subscribe
Scroll